Search for Clinical Trial Results

Sponsored By

Muckle-Wells Syndrome - 14 Studies Found

Status Study
Completed Study Name: Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome
Condition: Muckle Wells Syndrome
Date: 2007-04-25
Interventions:
  • Drug: ACZ885
  • Drug: Placebo
Completed Study Name: Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)
Condition:
  • Muckle-Wells Syndrome
  • Schnitzler Syndrome

Date: 2010-01-07
Interventions: Drug: rilonacept 160mg of rilonacept 1x/week Other N
Withdrawn Study Name: A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease
Condition:
  • Muckle Wells Syndrome
  • Autoinflammatory
  • Cryopyrin-Associated Periodic Syndromes
  • Familial Cold Autoinflammatory Syndrome
  • Date: 2008-05-27
    Interventions: Drug: Canakinumab (ACZ885) 6 mL glass vial containing 150 mg lyophilized Canakinumab reconstituted with
Completed Study Name: Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
Condition:
  • Cryopyrin-associated Periodic Syndromes
  • Familial Cold Autoinflammatory Syndrome
  • Date: 2011-02-22
    Interventions: Drug: ACZ885
Completed Study Name: Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase
Condition:
  • Cryopyrin-associated Periodic Syndromes
  • Familial Cold Autoinflammatory Syndrome
  • Date: 2009-10-06
    Interventions: Drug: canakinumab canakinumab
Completed Study Name: The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy
Condition: Dental Pulp Exposure
Date: 2005-09-13
Interventions:
  • Procedure: PP Partial pulpotom
Active, not recruiting Study Name: Continued Access to PREVAIL (CAP2)
Condition: Atrial Fibrillation
Date: 2012-11-06
Interventions: Device: WATCHMAN LAA Closure Technology
Completed Study Name: Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
Condition:
  • Familial Cold Autoinflammatory Syndrome (FCAS)
  • Familial Cold Urticaria
  • Drug: rilonacept 160 mg Rilona
Completed Study Name: Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms
Condition: NALP3 Mutation
Date: 2007-06-18
Interventions: Drug: canakinumab
Next >>>